Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicentral Retrospective Chart Review Study of Targeted Therapy Use in Patients With BRAF V600 Advanced (Unresectable or Metastatic) Cutaneous Melanoma in Routine Clinical Practice in Russian Federation

NCT03663647 is registered in ClinicalTrials.gov with MelanomaPRO, Russia as lead sponsor.

NCT NCT03663647
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03663647 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicentral Retrospective Chart Review Study of Targeted Therapy Use in Patients With BRAF V600 Advanced (Unresectable or Metastatic) Cutaneous Melanoma in Routine Clinical Practice in Russian Federation
Lead sponsor
MelanomaPRO, Russia
Phase
Observational
Overall status
Completed
Start date
October 8, 2018
Completion date
April 27, 2019
Enrollment
382 (actual)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

braf v600 mutation, cutaneous melanoma, stage iv